MAGELLAN HEALTH INC's ticker is MGLN and the CUSIP is 559079207.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,745,000 | +0.5% | 18,375 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $1,737,000 | -52.9% | 18,375 | -53.1% | 0.00% | -50.0% |
Q2 2021 | $3,690,000 | -1.5% | 39,175 | -2.5% | 0.01% | 0.0% |
Q1 2021 | $3,746,000 | -0.3% | 40,175 | -11.5% | 0.01% | 0.0% |
Q4 2020 | $3,759,000 | +9.3% | 45,375 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $3,439,000 | -2.2% | 45,375 | -5.8% | 0.01% | -11.1% |
Q2 2020 | $3,516,000 | +50.1% | 48,175 | -1.0% | 0.01% | +28.6% |
Q1 2020 | $2,342,000 | -50.7% | 48,684 | -19.8% | 0.01% | -36.4% |
Q4 2019 | $4,749,000 | +38.0% | 60,684 | +9.5% | 0.01% | +22.2% |
Q3 2019 | $3,441,000 | -19.0% | 55,407 | -3.1% | 0.01% | -18.2% |
Q2 2019 | $4,246,000 | +8.8% | 57,207 | -3.4% | 0.01% | +10.0% |
Q1 2019 | $3,903,000 | +7.2% | 59,207 | -7.5% | 0.01% | 0.0% |
Q4 2018 | $3,641,000 | -21.1% | 64,007 | 0.0% | 0.01% | -9.1% |
Q3 2018 | $4,612,000 | -24.9% | 64,007 | 0.0% | 0.01% | -26.7% |
Q2 2018 | $6,141,000 | -10.4% | 64,007 | 0.0% | 0.02% | -11.8% |
Q1 2018 | $6,855,000 | +11.8% | 64,007 | +0.8% | 0.02% | +13.3% |
Q4 2017 | $6,132,000 | +11.0% | 63,507 | -0.8% | 0.02% | +7.1% |
Q3 2017 | $5,524,000 | +20.5% | 64,007 | +1.7% | 0.01% | +16.7% |
Q2 2017 | $4,586,000 | +1.6% | 62,907 | -3.8% | 0.01% | 0.0% |
Q1 2017 | $4,516,000 | -8.2% | 65,407 | 0.0% | 0.01% | -7.7% |
Q4 2016 | $4,922,000 | +38.1% | 65,407 | -1.4% | 0.01% | +44.4% |
Q3 2016 | $3,563,000 | -18.4% | 66,307 | -0.2% | 0.01% | -18.2% |
Q2 2016 | $4,368,000 | -3.6% | 66,407 | -0.4% | 0.01% | -8.3% |
Q1 2016 | $4,531,000 | +10.0% | 66,707 | -0.1% | 0.01% | +9.1% |
Q4 2015 | $4,119,000 | +5.8% | 66,807 | -4.8% | 0.01% | 0.0% |
Q3 2015 | $3,892,000 | -20.9% | 70,206 | 0.0% | 0.01% | -15.4% |
Q2 2015 | $4,919,000 | +2.7% | 70,206 | +3.8% | 0.01% | +8.3% |
Q1 2015 | $4,788,000 | -41.3% | 67,606 | -50.2% | 0.01% | +20.0% |
Q4 2014 | $8,152,000 | +117.1% | 135,812 | +98.0% | 0.01% | 0.0% |
Q3 2014 | $3,755,000 | -11.5% | 68,606 | +0.6% | 0.01% | -9.1% |
Q2 2014 | $4,245,000 | +8.2% | 68,206 | +3.2% | 0.01% | +10.0% |
Q1 2014 | $3,923,000 | -4.5% | 66,106 | -3.6% | 0.01% | -9.1% |
Q4 2013 | $4,110,000 | -8.7% | 68,606 | -8.7% | 0.01% | -8.3% |
Q3 2013 | $4,503,000 | +4.6% | 75,106 | -2.2% | 0.01% | 0.0% |
Q2 2013 | $4,307,000 | – | 76,806 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Summit Street Capital Management, LLC | 57,796 | $3,926,000 | 4.08% |
Orbimed Advisors | 1,909,000 | $129,678,000 | 1.36% |
Smith, Graham & Co., Investment Advisors, LP | 153,331 | $10,416,000 | 1.36% |
Matarin Capital Management, LLC | 124,009 | $8,423,931,000 | 1.18% |
Assured Investment Management LLC | 590,986 | $40,146,000 | 0.88% |
Euclidean Technologies Management, LLC | 8,716 | $592,000 | 0.60% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 123,404 | $8,382,000 | 0.56% |
ALGERT GLOBAL LLC | 18,419 | $1,251,000 | 0.47% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 59,175 | $4,020,000 | 0.47% |
CAMBIAR INVESTORS LLC | 478,646 | $32,514,000 | 0.47% |